Archived from the original on 2009-06-21
BPC-157 Therapy The BPC-157 peptide is characterized by its ability to inhibit the increased expression of -defensins, LL-37, RNase 7, psoriasin, and lysozyme, which may make it one of the main factors responsible for reduced susceptibility to skin infections in patients with psoriasis
Krishna S, Low IC, Pervaiz S (2011) Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2
Less-selective compounds in the same class (GHRP-2, GHRP-6, hexarelin) cross-activate other endocrine axes alongside GH, which makes them noisier reference tools when researchers want to isolate ghrelin-pathway signalling from confounding hormonal effects
However, they may seem ineffective or fail to deliver the expected results
Bullon P, Cordero MD, Quiles JL, Morillo JM, del Carmen Ramirez- Tortosa M, Battino M